Clinical Trial Details
EORTC-1608-BTG
Back to Clinical Trials Database
Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients with Anaplastic Astrocytoma or Glioblastoma: A Phase Ib Study
| Trial Status | Closed to Patient Entry |
|---|---|
| Dates |
Date of activation: 06-Jun-2018 Date Step1 close: 27-Jul-2021 Date Step2 close: 27-Jul-2021 |
| Data management at EORTC | Yes |
| Design |
Phase 1 Not randomized / N.A. |
| Targeted Sample size | EORTC Groups: 81 - All Groups: 81 |
| Treatment |
Radiotherapy, Drug Temozolomide, TG02 |
| Study Staff |
Emilie Le Rhun (Study Coordinator) , UniversitaetsSpital Zurich - Neurology Clinic, Zurich Jose Casas (TR Scientist) , EORTC Headquarters, Brussels Enrico Clementel (QART Manager) , EORTC Headquarters, Brussels Coreen Corning (QART Manager) , EORTC Headquarters, Brussels Ruxandra Dionisie (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Beatrice Fournier (Clinical Scientist) , EORTC Headquarters, Brussels Thierry Gorlia (Statistician) , EORTC Headquarters, Brussels Anne-Sophie Govaerts (Clinical Scientist) , EORTC Headquarters, Brussels Hafida Lmalem (Imaging Officer) , EORTC Headquarters, Brussels Livia Meirsman (Project Manager) , EORTC Headquarters, Brussels Sara Meloen (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Axelle Nzokirantevye (Imaging DM) , EORTC Headquarters, Brussels Maarten Spruyt (Data Manager) , EORTC Headquarters, Brussels Eliza Starczewska (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels Tina Verschuere (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels |
| Type of cancer | Brain |
| Participating groups | EORTC Brain Tumor Group |
| Recruiting centers |
CHRU de Lille (LILLE CEDEX, France) CHU Lyon - Hopital neurologique Pierre Wertheimer (BRON CEDEX, France) Erasmus MC (Rotterdam, Netherlands) Gustave Roussy (VILLEJUIF CEDEX, France) Hopital de La Timone (APHM) (MARSEILLE, France) UniversitaetsKlinikum Heidelberg - Head Hospital (Heidelberg, Germany) UniversitaetsSpital Zurich (Zurich, Switzerland) Universitaetsklinikum Bonn (Bonn, Germany) Universitaetsklinikum Regensburg (Regensburg, Germany) Universitaetsklinikum Wien - AKH unikliniken (Vienna, Austria) University Hospital Frankfurt -Senckenberg Institute of Neurooncology (Frankfurt am Main, Germany) |
| Protocol summary | http://clinicaltrials.gov/study/NCT03224104 |
| NCT number | NCT03224104 |
| EudraCT | 2017-001029-42 |
| Financial Support | Educational Grant |
